employer glp-1 coverage news Rising Costs for Weight Loss Drugs Impact Health | Ukraine GLP-1 Insurance Coverage Statistics 2026

Phase 2 clinical trial data published in 2023 in the New England Journal of Medicine demonstrated that participants receiving the highest dose of retatrutide achieved a mean body weight reduction of approximately 24% over 48 weeks results that have generated considerable scientific interest

Retrieved from Lilly-b

Glucagon-like peptide-1 (GLP-1) is an incretin hormone naturally produced by specialized L-cells in the distal small intestine and colon

Credible Coverage for Small Group Prescription Drug Design Notices in Eastern PA Central PA Please see below applicable to Highmarks Central PA Region (files as Highmark Blue Shield only)